Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| HT94252310316 | Other Grant/Funding Number | Department of Defense |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| United States Department of Defense | FED |
Not provided
Not provided
Not provided
A pilot study on simulated lung scenarios using the standard manual resuscitator bag, flow limiting resuscitator bag, and an FDA approved flow rate limiting device paired with a standard manual resuscitator.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ambu + Normal lung compliance | No Intervention | Manual ventilation with Ambu bag and normal lung compliance. | |
| Ambu + Low lung compliance | No Intervention | Manual ventilation with Ambu bag and low lung compliance. | |
| Smart bag + Normal lung compliance | No Intervention | Manual ventilation with smart bag and normal lung compliance. | |
| Smart bag + Low lung compliance | No Intervention | Manual ventilation with smart bag and low lung compliance. | |
| Ambu + Sotair + Normal lung compliance | Active Comparator | Manual ventilation with Ambu bag and Sotair device with normal lung compliance. |
|
| Ambu + Sotair + Low compliance | Active Comparator | Manual ventilation with Ambu bag and Sotair device with low lung compliance. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sotair | Device | The device is a durable plastic connector with a silicone flap inside it requiring no special handling. There are no patients involved, only a simulated lung that also requires no special handling. Adult Sotair® device has FDA clearance as a Class II device through the 510(k) pathway (K212905) for the intended use of "Flow-limiting, safe, and optimal manual ventilation to minimize gastric insufflation." |
| Measure | Description | Time Frame |
|---|---|---|
| Minute ventilation while manually ventilating the simulated lung | The primary Ventilation endpoint is minute ventilation while manually ventilating the simulated lung over the course of 10 hours. | 10 hours of manual ventilation |
| Minute ventilation while manually ventilating the simulated lung | The major endpoints of the subjects response to performing the manual ventilation will be: Respiratory rate and heart rate; Samn-Perelli 7-point fatigue scale reported hourly; Modified Borg Rating of Perceived Exertion 10-point scale reported hourly. | 10 hours of manual ventilation |
| Measure | Description | Time Frame |
|---|---|---|
| Secondary Outcome Measure | Secondary endpoints include: tidal volume, peak inspiratory pressure, respiratory rate, and estimated alveolar ventilation while ventilating the simulated lung. | 10 hours of manual ventilation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mark Brady, MD | Brown Physicians, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Brown Physicians, Inc | Providence | Rhode Island | 02903 | United States |
Decision has not been determined.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|